Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial

BACKGROUND: Natural killer (NK) cells are one of the main effector populations of immunotherapy with monoclonal antibody and cytokines, used in combination with chemotherapy to treat children with high-risk neuroblastoma on this phase II trial. However, the impact of chemoimmunotherapy on NK cell ki...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Immunother Cancer
Egile Nagusiak: Nguyen, Rosa, Sahr, Natasha, Sykes, April, McCarville, Mary Beth, Federico, Sara M, Sooter, Amanda, Cullins, David, Rooney, Barbara, Janssen, William E, Talleur, Aimee C, Triplett, Brandon M, Anthony, Gwendolyn, Dyer, Michael A, Pappo, Alberto S, Leung, Wing H, Furman, Wayne L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Short Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7206969/
https://ncbi.nlm.nih.gov/pubmed/32221013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000176
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak